Skip to content

Application of the whole-path "5E" rehabilitation nursing model in accelerated recovery of patients with thoracoscopic resection of lung cancer: a parallel randomized controlled trial

Application of the whole-path "5E" rehabilitation nursing model in accelerated recovery of patients with thoracoscopic resection of lung cancer: a parallel randomized controlled trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200062660
Enrollment
Unknown
Registered
2022-08-15
Start date
2022-08-01
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Observation group:Full pathway "5E" rehabilitation care model
control group:Routine accelerated rehabilitation care

Sponsors

Department of Thoracic Surgery, Zhongnan Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 59 Years

Inclusion criteria

Inclusion criteria: 1. Patients who are suitable for thoracoscopic lobectomy and systematic lymph node dissection after evaluation by thoracic specialists; 2. Aged 18-59 years; Clinical staging showed stage I, II or IIIA lung cancer; 3. Patients without motor system diseases; 4. No history of thoracotomy and upper abdominal surgery; 5. Informed consent; 6. Did not participate in the same type of study before surgery.

Exclusion criteria

Exclusion criteria: 1. Conversion of intraoperative massive bleeding to thoracotomy or pneumonectomy; 2. Patients who need to stop bleeding again after operation; 3. Patients with severe cardiopulmonary and brain diseases (AMI, AECOPD, cerebral hemorrhage), severe liver and kidney insufficiency or end-stage disease before surgery; 4. Can not cooperate (intellectual disorder, consciousness disorder, mental abnormality); 5. Patients diagnosed as non-primary lung cancer by pathological examination; 6. Protective medicine, do not know the diagnosis of cancer.

Design outcomes

Primary

MeasureTime frame
6-minute walk test;Borg Dyspnea Score;Vital signs;Postoperative complications;Lung function;

Secondary

MeasureTime frame
Postoperative hospital stay;Hospitalization cost;Anderson Symptom Assessment Scale score;QLQ-C30 + QLQ-LC13;Hospital Anxiety depression Scale;

Countries

China

Contacts

Public ContactJian Yang

Department of thoracic surgery, Zhongnan Hospital of Wuhan University

yangjian1812232@163.com+86 13638694573

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026